Summit Therapeutics Inc. Quarterly Operating Lease, Liability, Noncurrent in USD from Q4 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary
Summit Therapeutics Inc. quarterly Operating Lease, Liability, Noncurrent history and growth rate from Q4 2017 to Q3 2024.
  • Summit Therapeutics Inc. Operating Lease, Liability, Noncurrent for the quarter ending September 30, 2024 was $4.21M, a 8.46% increase year-over-year.
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Operating Lease, Liability, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $4.21M +$328K +8.46% Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $5.02M +$686K +15.8% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $5.82M +$3.33M +134% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $3.29M +$527K +19.1% Dec 31, 2023 10-Q 2024-10-30
Q3 2023 $3.88M +$906K +30.5% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $4.33M +$3.01M +228% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $2.49M +$956K +62.3% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $2.76M +$1.07M +63.4% Dec 31, 2022 10-K 2024-02-20
Q3 2022 $2.97M +$2.08M +232% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $1.32M +$174K +15.2% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $1.54M +$1.18M +337% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 $1.69M +$1.62M +2155% Dec 31, 2021 10-K 2023-03-09
Q3 2021 $896K +$734K +453% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $1.15M +$918K +399% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $351K Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $75K -$347K -82.2% Dec 31, 2020 10-K/A 2022-12-21
Q3 2020 $162K Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $230K Jun 30, 2020 8-K 2020-09-29
Q4 2019 $422K -$427K -50.3% Dec 31, 2019 10-K 2021-03-31
Q4 2018 $849K -$515K -37.8% Jan 31, 2019 8-K 2020-09-29
Q4 2017 $1.36M Jan 31, 2018 8-K 2020-09-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.